Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection

Journal of Neurology Neurosurgery and Psychiatry

Volumn 66, Issue 3, 1999, Pages 376-379

  Khalili Shirazi, Azadeh ^a,b   Gregson, Norman ^a   Gray, Ian ^a   Rees, Jeremy ^a   Winer, John ^a   Hughes, Richard ^a  

^a UMDS   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cytomegalovirus; Ganglioside GM2; Guillan Barr ; Syndrome

Indexed keywords

GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1; GANGLIOSIDE GM2; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AUTOANTIBODIES; CYTOMEGALOVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; G(M2) GANGLIOSIDE; GANGLIOSIDES; HUMANS; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY;

EID: 0032938736     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.66.3.376     Document Type: Article

References (17)

1. Ilyas AA, Mithen FA, Chen Z-W, et al. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome. J Neurol Sci 1991;102:67-75.
2. Yuki N, Tagawa Y, Irie F, et al. Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1a. J Neuroimmunol 1997;74:30-4.
3. Winer JB, Hughes RAC, Anderson MJ, et al. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 1988;51:613-8.
4. Visser LH, Van der Meché FGA, Meulstee J, et al. Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Neurology 1996;47:668-73.
5. Niwa K, Kitagawa Y, Ohta T, et al. A case of Guillain-Barré syndrome associated with anti-GM2 antibody due to cytomegalovirus infection-special reference to the effect of ganciclovir. Clin Neurol 1995;35:652-6.
6. 2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection. J Neuroimmunol 1996;68:19-26.
7. Jacobs BC, van Doorn PA, Groeneveld JHM, et al. Cytomegalovirus infections and anti-GM2 antibodies in Guillan-Barré syndrome. J Neurol Neurosurg Psychiatry 1997;62: 641-3.
8. Yuki N, Tagawa Y. Acute cytomegalovirus infection and IgM anti-GM2 antibody. J Neurol Sci 1998;154:14-17
9. 1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38: 809-16.
10. Mizutamari RK, Wiegandt H, Nores GA. Characterisation of anti-ganglioside antibodies present in normal human plasma. J Neuroimmunol 1994;50:215-20.
11. Gregson NA, Jones D, Willison HJ. Antibodies against GM1 and other gangliosides in patients with motor neuron syndromes. New evidence in MND/ALS research. London: Smith-Gordon, 1991:197-208.
12. Hughes RAC, Atkinson P, Coates P, et al. Sural nerve biopsies in Guillain-Barré syndrome: axonal degeneration and macrophage-mediated demyelination and absence of cytomegalovirus genome. Muscle Nerve 1992;15:568-75.
13. Webb HE. Anti-glycolipid immunity. Neuropathogenic viruses and immunity. New York: Plenum Press, 1992:277-302.
14. Scott LJC, Bacou F, Sanes F. A synapse-specific carbohydrate at the neuromuscular junction: association with both acetylcholinesterase and a glycolipid. J Neurol Sci 1988;8: 932-944.
15. Ritter G, Fortunato SR, Cohen L, et al. Induction of antibodies reactive with GM2 ganglioside after immunisation with lipopolysaccharides from Campylobacter jejuni. Int J Cancer 1996;66:184-90.
16. Ilyas AA, Li S-C, Chou DKH, et al. Ganglioside G(M2), IV4GalNAcG(M1b), and IV4GalNAcG(D1a) as antigens for monoclonal immunoglobulin M in neuropathy associ-ated with gammapathy. J Biol Chem 1988;263:4369-73.
17. Kusunoki S, Chiba A, Kon K, et al. N-acetylgalactosamine GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol 1994;35:570-6.